Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Guicaobaidu Decoction is a traditional Chinese medicine (TCM) herbal formula used primarily to mitigate chemotherapy-induced myocardial injury, particularly doxorubicin-induced cardiotoxicity. Preclinical studies indicate that it exerts cardioprotective effects by upregulating the expression of TRDMT1 and modulating BNIP3-mediated mitophagy pathways, thereby improving mitochondrial function and reducing cardiac cell damage during chemotherapy. The decoction may also influence m5C RNA methylation processes related to myocardial protection[1][3][8]. Its mechanism involves modulation of cellular stress responses and enhancement of cardiac resilience during chemotherapeutic regimens.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Guicaobaidu Decoction.